Indeed, some studies have already reported the use of stem cells in wound healing in diabetes, such as Barcelos et al., who evaluated the healing potential of the human fetal aorta-derived CD133+ progenitor cells in a model of ischemic diabetic ulcer, reporting an accelerated wound closure.27 Here, PROM1 is linked to diabetes mellitus.